Discontinued — last reported Q4 '20
UnitedHealth Group Available-for-Sale Debt Securities increased by 0.5% to $46.82B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 1.2%, from $46.26B to $46.82B. Over 4 years (FY 2020 to FY 2024), Available-for-Sale Debt Securities shows an upward trend with a 4.2% CAGR.
An increase indicates the company is deploying excess cash into interest-bearing securities, while a decrease suggests liquidation for operational needs or acquisitions.
These are debt instruments held by the company that are not classified as trading or held-to-maturity securities. They a...
Common among large-cap tech firms with significant cash balances; peers often hold similar portfolios to earn yield on idle cash.
afs_debt_securities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $42.13B | $42.76B | $40.22B | $39.84B | $40.00B | $39.55B | $42.32B | $45.38B | $44.13B | $44.35B | $44.90B | $44.13B | $44.73B | $46.26B | $46.92B | $46.45B | $46.61B | $46.82B |
| QoQ Change | — | +1.5% | -5.9% | -0.9% | +0.4% | -1.1% | +7.0% | +7.2% | -2.8% | +0.5% | +1.2% | -1.7% | +1.4% | +3.4% | +1.4% | -1.0% | +0.3% | +0.5% |
| YoY Change | — | — | — | — | -5.0% | -7.5% | +5.2% | +13.9% | +10.3% | +12.1% | +6.1% | -2.8% | +1.4% | +4.3% | +4.5% | +5.2% | +4.2% | +1.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.